- VIVUS Announces $110 Million Synthetic Capped Royalty Financing - Mar. 26, 2013
- VIVUS Confirms Receipt of Notice of Nomination From First Manhattan Co. - Mar. 08, 2013
- VIVUS to Present at Three Investor Conferences in March 2013 - Mar. 04, 2013
- VIVUS Reports 2012 Fourth Quarter and Full-Year Financial Results - Feb. 25, 2013
- VIVUS Receives Decision Regarding Qsiva Appeal - Feb. 21, 2013
- VIVUS Announces Date of Fourth Quarter and Fiscal Year 2012 Financial Results and Conference Call - Feb. 20, 2013
- VIVUS to Present at Three Investor Conferences in February 2013 - Feb. 08, 2013
- Study Concludes That Weight Loss With Qsymia™ Significantly Improves Multiple Cardiovascular Disease Risk Factors - Feb. 01, 2013
- VIVUS to Present at the 2013 JP Morgan Healthcare Conference - Jan. 04, 2013
- VIVUS Announces Express Scripts Adds Qsymia (Phentermine And Topiramate Extended-Release) Capsules CIV To Its Standard Benefits Program - Dec. 20, 2012
- VIVUS To Present New Data On Qsymia™ At 30th Annual Scientific Meeting of The Obesity Society - Sep. 20, 2012
-
Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW - Feb. 24, 2013
-
Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX - Dec. 09, 2012
-
Weekly Guru Bargains Highlights: CIG, PWE, VVUS, EBR, ATHN - Dec. 03, 2012
-
Passport’s John Burbank Boosts VIVUS Stake to 8.5 Pct of Company - Nov. 02, 2012
-
Weekly Top Insider Buys: IRM, JCP, APU, CAB, VVUS - Aug. 27, 2012
VIVUS Inc. Reports Operating Results (10-Q) - Aug. 07, 2012
-
Weekly CEO Sells Highlight: Splunk Inc, eBay Inc, Skyworks Solutions Inc, and VIVUS Inc. - Jul. 28, 2012
-
Weekly CEO Sells Highlight: GTx, Inc, VIVUS, Inc, Time Warner Inc. - Jul. 22, 2012
-
Weekly CFO Sells Highlight: PII, ASNA, FIO, VVUS, AFFY - Jul. 23, 2012
VIVUS Inc. (VVUS) CEO Leland F Wilson sells 100,000 Shares - Jul. 20, 2012
VIVUS Inc. (VVUS) VP, Finance and CFO Timothy E Morris sells 25,000 Shares - Jul. 20, 2012
-
The Short Case for Vivus - Jul. 20, 2012
VIVUS Inc. (VVUS) CEO Leland F Wilson sells 50,000 Shares - Jul. 02, 2012
- FDA Advisory Committee Recommends Approval of Qnexa® - Feb. 22, 2012
VIVUS Inc. (VVUS) CEO Leland F Wilson sells 50,000 Shares - Jun. 13, 2012
-
Arena Facing Increased Pressure from Peers - Apr. 23, 2012
-
Arena Could Dip If Lorcaserin Fails Again - Apr. 22, 2012
-
Vivus Could Rocket on Success of Qnexa - Apr. 13, 2012
-
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN - Mar. 04, 2012
VIVUS Inc. Reports Operating Results (10-K) - Feb. 28, 2012
VIVUS Inc. (VVUS) CEO Leland F Wilson sells 50,000 Shares - Feb. 28, 2012
VIVUS Inc. (VVUS) SVP, Finance and CFO Timothy E Morris sells 329,358 Shares - Feb. 27, 2012
- VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity - Dec. 23, 2011
VIVUS Inc. (VVUS) CEO Leland F Wilson sells 150,000 Shares - Feb. 24, 2012
- VIVUS Reports Topline Findings From FORTRESS - Dec. 21, 2011
- SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years - Dec. 08, 2011
- Weight Loss and Effects on Diabetes with Qnexa Treatment Results Presented at the World Diabetes Congress - Dec. 07, 2011
- Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment - Nov. 03, 2011
-
Options V: Short-Term Strategy – Earning Money on Volatility - Oct. 19, 2011
Total Records: 67 Page: 1 2  |
|
European Shorting
VVUS has been successfully added into Your Stock Email Alerts list.
Feedback
My Portfolios
Browse Gurus
Bookmark
Add to Portfolio
Get Email Alerts
RSS Update
Company Website
SEC Reports
RSS